Geneoscopy is a molecular diagnostics company committed to providing safe, effective, and innovative non-invasive tests to improve the diagnosis, monitoring, and treatment of gastrointestinal diseases. The Company has developed a proprietary method to isolate eukaryotic RNA biomarkers from stool samples. This platform has been used to build a noninvasive diagnostic that can detect both colorectal cancer and precancercous adenomas with high sensitivity. Geneoscopy’s RNA extraction platform enables access to a variety of clinically relevant biomarkers, including: GI enterocytes, lymphocytes, and can assess host-microbiome interaction. This provides for opportunities such as standalone tests, companion diagnostics, and/or clinical trial tools.